299 related articles for article (PubMed ID: 1847588)
1. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
Guijarro LG; Rodriguez-Pena MS; Prieto JC
Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
[TBL] [Abstract][Full Text] [Related]
2. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
Provow S; Veliçelebi G
Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of receptors for VIP in rat peritoneal macrophage membranes.
Calvo JR; Guerrero JM; López-Gonzalez MA; Osuna C; Segura JJ
Peptides; 1994; 15(2):309-15. PubMed ID: 8008637
[TBL] [Abstract][Full Text] [Related]
4. Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein.
Couvineau A; Amiranoff B; Laburthe M
J Biol Chem; 1986 Nov; 261(31):14482-9. PubMed ID: 3021741
[TBL] [Abstract][Full Text] [Related]
5. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
6. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium.
Elgavish A; Pillion DJ; Meezan E
Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697
[TBL] [Abstract][Full Text] [Related]
7. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
Couvineau A; Gammeltoft S; Laburthe M
J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175
[TBL] [Abstract][Full Text] [Related]
10. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
Dickinson KE; Schachter M; Miles CM; Coy DH; Sever PS
Peptides; 1986; 7(5):791-800. PubMed ID: 3025822
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
12. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
13. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
[TBL] [Abstract][Full Text] [Related]
14. Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors.
Patthi S; Simerson S; Veliçelebi G
J Biol Chem; 1988 Dec; 263(36):19363-9. PubMed ID: 2848823
[TBL] [Abstract][Full Text] [Related]
15. Solubilization and hydrodynamic characterization of guanine nucleotide sensitive vasoactive intestinal peptide-receptor complexes from rat intestine.
Calvo JR; Couvineau A; Guijarro L; Laburthe M
Biochemistry; 1989 Feb; 28(4):1667-72. PubMed ID: 2541761
[TBL] [Abstract][Full Text] [Related]
16. VIP receptor-effector system in rat harderian gland and its coupling to activation of type II thyroxine 5'-deiodinase.
Calvo JR; Caraballo MI; Pozo D; Segura JJ; Osuna C; Guerrero JM
Peptides; 1995; 16(3):551-7. PubMed ID: 7651912
[TBL] [Abstract][Full Text] [Related]
17. Characterization of binding sites for beta-adrenergic agonists and vasoactive intestinal peptide in the rat harderian gland.
Guerrero JM; Osuna C; Molinero P; Caraballo MI; Harmouch A; Pozo D; Rafii-el-Idrissi M; Garcia-Macias JF; Calvo JR
Microsc Res Tech; 1996 Jun; 34(2):139-43. PubMed ID: 8722708
[TBL] [Abstract][Full Text] [Related]
18. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
[TBL] [Abstract][Full Text] [Related]
19. Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver.
Guijarro L; Couvineau A; Calvo JR; Laburthe M
Regul Pept; 1989 Apr; 25(1):37-50. PubMed ID: 2541470
[TBL] [Abstract][Full Text] [Related]
20. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
Paul S; Said SI
J Biol Chem; 1987 Jan; 262(1):158-62. PubMed ID: 3025200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
